Skip to main content

Academic Venture Fund

Small Device, Big Results
Return to Academic Venture Fund

2017: Small Device, Big Results

A pocket-sized device promises health workers around the world an easy, inexpensive way to detect antibiotic resistance and manage infections–right in the doctor’s office or clinic. Partnering with Weill Cornell Medicine, the researchers will develop Rapid Identification of Antibiotic Resistance (RIDAR), a handheld diagnostic tool that delivers near-instant information about a patient’s infection type to reduce unnecessary antibiotic use. If the infection is bacterial, RIDAR will check its antibiotic susceptibility and suggest the most effective drug for treatment.

[Thanks to a generous gift from David Atkinson, this project is partly sponsored by Cornell’s new Master of Public Health (MPH)–an interdisciplinary program using a One Health approach.]

Investigators: Saurabh MehtaDavid Erickson, Marshall Glesby (Weill), Lars Westblade (Weill)

Sign up for our newsletter: